Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4589173018 | Ertugliflozin pidolate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4589174012 | Ertugliflozin pidolate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ertugliflozin pidolate | Is a | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Ertugliflozin pidolate | Has disposition | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Ertugliflozin pidolate | Is modification of | Ertugliflozin | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Ertugliflozin pidolate | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Ertugliflozin pidolate | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR